The American Journal of Medicine
Volume 116, Issue 11 , Pages 732-739 , 1 June 2004

Case management for patients with poorly controlled diabetes: a randomized trial

  • Sarah L Krein, PhD, RN

      Affiliations

    • VA Health Services Research and Development Center for Practice Management and Outcomes Research (SLK, MLK, SV, RAH), Ann Arbor, Michigan, USA
    • Departments of Internal Medicine (SLK, SV, PR, RAH), Ann Arbor, USA
    • The Michigan Diabetes Research and Training Center (SLK, SV, RAH), Ann Arbor, USA
    • Corresponding Author InformationRequests for reprints should be addressed to Sarah L. Krein, PhD, RN, VA HSR&D, P.O. Box 130170, Ann Arbor, Michigan, USA 48113–0170
    • ,
  • Mandi L Klamerus, MPH

      Affiliations

    • VA Health Services Research and Development Center for Practice Management and Outcomes Research (SLK, MLK, SV, RAH), Ann Arbor, Michigan, USA
    • ,
  • Sandeep Vijan, MD, MS

      Affiliations

    • VA Health Services Research and Development Center for Practice Management and Outcomes Research (SLK, MLK, SV, RAH), Ann Arbor, Michigan, USA
    • Departments of Internal Medicine (SLK, SV, PR, RAH), Ann Arbor, USA
    • The Michigan Diabetes Research and Training Center (SLK, SV, RAH), Ann Arbor, USA
    • ,
  • Jan L Lee, RN, PhD

      Affiliations

    • University of Tennessee College of Nursing (JLL), Knoxville, USA
    • ,
  • James T Fitzgerald, PhD

      Affiliations

    • VA GRECC (JTF), VA Ann Arbor Healthcare System, Ann Arbor, Michigan, USA
    • Medical Education (JTF), University of Michigan School of Medicine, Ann Arbor, USA
    • ,
  • Alan Pawlow, MD

      Affiliations

    • John D. Dingell VA Medical Center and Department of Internal Medicine (AP), Wayne State University, Detroit, Michigan, USA
    • ,
  • Pamela Reeves, MD

      Affiliations

    • VA Veterans In Partnership (PR), VISN 11 Healthcare Network, Ann Arbor, Michigan, USA
    • Departments of Internal Medicine (SLK, SV, PR, RAH), Ann Arbor, USA
    • ,
  • Rodney A Hayward, MD

      Affiliations

    • VA Health Services Research and Development Center for Practice Management and Outcomes Research (SLK, MLK, SV, RAH), Ann Arbor, Michigan, USA
    • Departments of Internal Medicine (SLK, SV, PR, RAH), Ann Arbor, USA
    • The Michigan Diabetes Research and Training Center (SLK, SV, RAH), Ann Arbor, USA

Received 1 May 2003 ,Revised 20 November 2003 ,Accepted 20 November 2003.

References 

  1. Vijan S, Stevens DL, Herman WH, Funnell MM, Standiford CJ. Screening, prevention, counseling and treatment for the complications of type II diabetes mellitus (putting evidence into practice). J Gen Intern Med. 1997;12:567–580
  2. National Diabetes Data Group . Diabetes in America. 2nd ed. Bethesda, Maryland: National Institutes of Health; 1995;
  3. de Grauw WJ, van de Lisdonk EH, van den Hoogen HJ, van Weel C. Cardiovascular morbidity and mortality in type 2 diabetic patients (a 22-year historical cohort study in Dutch general practice). Diabet Med. 1995;12:117–122
  4. Harris MI, Flegal KM, Cowie CC, et al. , Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in US  adults. Diabetes Care. 1998;21:518–524
  5. Hogan P, Dall T, Nikolov P. Economic costs of diabetes in the U.S. in 2002. Diabetes Care. 2003;26:917–932
  6. UK Prospective Diabetes Study Group (UKPDS) . Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–853
  7. UK Prospective Diabetes Study Group (UKPDS) . Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352:854–865
  8. UK Prospective Diabetes Study Group (UKPDS) . Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38). BMJ. 1998;317:703–713
  9. UK Prospective Diabetes Study Group (UKPDS) . Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 39). BMJ. 1998;317:713–720
  10. The Diabetes Control and Complications Trial Research Group . The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–986
  11. The Early Treatment of Diabetic Retinopathy Study Research Group . Early photocoagulation for diabetic retinopathy. ETDRS Report Number 9. Ophthalmology. 1991;98(suppl):766–785
  12. Peters AL, Legorreta AP, Ossorio RC, Davidson MB. Quality of outpatient care provided to diabetic patients. a health maintenance organization experience. Diabetes Care. 1996;19:601–606
  13. Sperl-Hillen J, O'Connor PJ, Carlson RR, et al.  Improving diabetes care in a large health care system (an enhanced primary care approach). J Qual Improve. 2000;26:615–621
  14. Saaddine J, Engelgau M, Beckles G, Gregg E, Thompson T, Narayan K. A diabetes report card for the United States (quality of care in the 1990s). Ann Intern Med. 2002;136:565–574
  15. Gilmer TP, O'Connor PJ, Manning WG, Rush WA. The cost to health plans of poor glycemic control. Diabetes Care. 1997;20:1847–1853
  16. Vijan S, Hofer TP, Hayward RA. Estimated benefits of glycemic control in microvascular complications in type 2 diabetes. Ann Intern Med. 1997;127:788–795
  17. Stratton IM, Adler AI, Neil HAW, et al.  Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35) (prospective observation study). BMJ. 2000;321:405–412
  18. Tanaka Y, Atsumi Y, Matsuoka K, Onuma T, Tohjima T, Kawamori R. Role of glycemic control and blood pressure in the development and progression of nephropathy in elderly Japanese NIDDM patients. Diabetes Care. 1998;21:116–120
  19. DeBusk R, West J, Miller N, Taylor C. Chronic disease management (treating the patient with disease(s) vs treating disease(s) in the patient). Arch Intern Med. 1999;159:2739–2742
  20. Aubert RE, Herman WH, Water J, et al.  Nurse case management to improve glycemic control in diabetic patients in a health maintenance organization. Ann Intern Med. 1998;129:605–612
  21. Katon W, Von Korff M, Lin E, Simon G. Rethinking practitioner roles in chronic illness (the specialist, primary care physician, and the practice nurse). Gen Hosp Psychiatry. 2001;23:138–144
  22. Norris SL, Nichols PJ, Caspersen CJ, et al.  The effectiveness of disease and case management for people with diabetes. A systematic review. Am J Prev Med. 2002;22:15–38
  23. Commission for Case Manager Certification. CCM Certification Guide, Certified Case Manager. Rolling Meadows, Illinois: Commission for Case Manager Certification; 1996
  24. Ellrodt G, Cook DJ, Lee J, Cho M, Hunt D, Weingarten S. Evidence-based disease management. JAMA. 1997;278:1687–1692
  25. Ferguson JA, Weinberger M. Case management programs in primary care. J Gen Intern Med. 1998;13:123–126
  26. Mechanic RE. Disease Management (A Promising Approach for Health Care Purchaser. Executive Brief). Washington, D.C: National Health Care Purchasing Institute; 2002;
  27. Bodenheimer T. Disease management in the American market. BMJ. 2000;320:563–566
  28. Rector TS, Venus PA. Judging the value of population-based disease management. Inquiry. 1999;36:122–126
  29. Klonoff DC, Schwartz DM. An economic analysis of interventions for diabetes. Diabetes Care. 2000;23:390–404
  30. Weinberger M, Kirkman MS, Samsa GP, et al.  A nurse-coordinated intervention for primary care patients with non-insulin-dependent diabetes mellitus (impact on glycemic control and health-related quality of life). J Gen Intern Med. 1995;10:59–66
  31. Glasgow RE, Hiss RG, Anderson RM, et al.  Report of the health care delivery work group (behavioral research related to the establishment of a chronic disease model for diabetes care). Diabetes Care. 2001;24:124–130
  32. Wagner EH, Glasgow RE, Davis C, et al.  Quality improvement in chronic illness care (a collaborative approach). Jt Comm J Qual Improv. 2001;27:63–80
  33. Krein SL, Hayward RA, Pogach L, BootsMiller BB. Department of Veterans Affairs' Quality Enhancement Research Initiative for diabetes mellitus. Med Care. 2000;38:I38–I48
  34. Pogach LM, Hawley G, Weinstock R, et al.  Diabetes prevalence and hospital and pharmacy use in the Veterans Health Administration (1994). Diabetes Care. 1998;21:368–373
  35. Campbell DT, Stanley JC. Experimental and Quasi-Experimental Designs for Research. Boston, Massachusetts: Houghton Mifflin Company; 1963;
  36. The Diabetes Mellitus Working Group. Veterans Health Administration Clinical Guideline for Management of Diabetes Mellitus. Version 1.0. Washington, D.C.: Department of Veterans Affairs; 1997
  37. Peters AL, Davidson MB. Application of a diabetes managed care program. Diabetes Care. 1998;21:1037–1043
  38. Menke TJ, Homan RH, Kashner M. Determining costs in VA (research design problems and solutions illustrated with case studies). Med Care. 1999;37:AS18–AS26
  39. Haffner SM. Diabetes, hyperlipidemia, and coronary artery disease. Am J Cardiol. 1999;83:17F–21F
  40. Hansson L, Zanchetti A, Carruthers SG, et al.  Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension (principal results of the Hypertension Optimal Treatment (HOT) randomised trial). Lancet. 1998;351:1755–1762
  41. Kazis L, Miller DR, Clark J, et al.  Health-related quality of life in patients served by the Department of Veterans Affairs. Arch Intern Med. 1998;158:626–632
  42. Ware JE, Snyder MK, Wright WR, Davies AR. Defining and measuring patient satisfaction with medical care. Eval Prog Plan. 1983;6:247–263
  43. Clinical Classifications Software. Rockville, Maryland: Agency for Healthcare Research and Quality; 2000
  44. Miles M, Huberman AM. Qualitative Data Analysis (A Sourcebook of New Methods). Newbury Park, California: SAGE Publications; 1984;
  45. Glasgow RE, Hiss RG, Anderson RM, et al.  Report of the Health Care Delivery Work Group (behavioral research related to the establishment of a chronic disease model for diabetes care). Diabetes Care. 2001;24:1–2
  46. Steffens B. Cost-effective management of type 2 diabetes (providing quality care in a cost-constrained environment). Am J Manag Care. 2000;6(suppl):S697–S703
  47. Sidorov J, Gabbay R, Harris R, et al.  Disease management for diabetes mellitus (impact on hemoglobin A1c). Am J Manag Care. 2000;6:1217–1226
  48. Domurat ES. Diabetes managed care and clinical outcomes (the Harbor City, California Kaiser Permanente diabetes care system). Am J Manag Care. 1999;5:1299–1307
  49. Sackett D, Straus S, Richardson S, Rosenberg W, Haynes RB. Evidence-Based Medicine (How to Practice and Teach EBM). London, United Kingdom: Churchill Livingstone; 2000;

☆ This research was supported by the Office of Research and Development, Health Services Research and Development Service, Department of Veterans Affairs (IIR 970771). This work was also supported in part by the Michigan Diabetes Research and Training Center Grant P60DK-20572 from the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health, Bethesda, Maryland. Dr. Vijan is a Department of Veterans Affairs Career Development Awardee. The views expressed in this article are those of the authors and do not necessarily represent the views of the Department of Veterans Affairs.

PII: S0002-9343(04)00063-4

doi: 10.1016/j.amjmed.2003.11.028

The American Journal of Medicine
Volume 116, Issue 11 , Pages 732-739 , 1 June 2004

Article Tools

* Image Usage & Resolution